Q1, as a comparison toolHere is an exerpt of the Q1 results texts. This is by no mean the detailed version but an interesting paragraph that could quickly help us determine if there has been some progress tomorrow before jumping into a more detailed analysis:
''Q1 2019 Financial Results
All amounts are expressed in U.S. dollars unless otherwise stated and results are reported in accordance with International Financial Reporting Standards.
For the three-month period ended March 31, 2019, we reported a consolidated net loss of $6.0 million, or $0.05 loss per common share, as compared with a consolidated net loss of $0.6 million, or $0.00 loss per common share, for the same period in 2018. The $5.4 million increased loss results from the $4.6 million impact of the revaluation of warrants, the $0.2 million increase in general and administrative costs and the $0.7 million increase in finance costs offset by $0.1 million from a combination of increased revenue and reduced cost of sales.
Test volume at approximately 1600 tests showed an increase over Q4 and is showing growth in Q2 as the new programs are launched.
The Company's financial statements and management's discussion and analysis are available on www.sedar.com.''
This was published on May 16th. I highlighted a sentence wich I think is quite interesting. Already in March, it seemed that they were seeing an uptick in test numbers. Did that growth had enough momentum to last the whole quarter? That's what we're going to learn in a few hours.
Good luck, my friends.